Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE215945 | ||||||||
GSM6637903 |
LNCaP cells, DMSO treatment, 1
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6637904 |
LNCaP cells, DMSO treatment, 2
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6637905 |
LNCaP cells, DMSO treatment, 3
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6637906 |
LNCaP cells, Enzalutamide treatment, 14 days, 1
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6637907 |
LNCaP cells, Enzalutamide treatment, 14 days, 2
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6637908 |
LNCaP cells, Enzalutamide treatment, 14 days, 3
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6647951 |
LNCaP cells, DMSO treatment
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6647952 |
LNCaP cells, Enzalutamide treatment, 4 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6647953 |
LNCaP cells, Enzalutamide treatment, 7 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6647954 |
LNCaP cells, Enzalutamide treatment, 14 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658945 |
IgG LNCaP cells, DMSO treatment
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658946 |
H3K4me3 LNCaP cells, DMSO treatment
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658947 |
H3K27me3 LNCaP cells, DMSO treatment
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658948 |
H3K27ac LNCaP cells, DMSO treatment
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658949 |
IgG LNCaP cells, Enzalutamide treatment, 14 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658950 |
H3K4me3 LNCaP cells, Enzalutamide treatment, 14 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658951 |
H3K27me3 LNCaP cells, Enzalutamide treatment, 14 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 | |||
GSM6658952 |
H3K27ac LNCaP cells, Enzalutamide treatment, 14 days
|
SRA | 1 |
|
Changdeng Hu | Oct 28, 2022 |